Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Our goal is never to change the way you look, but to highlight what already makes you beautiful
Glucagon promotes satiety and increases energy expenditure in humans
Patients frequently report reduced pain, quicker healing times, and improved movement
Because it avoids those receptors, AOD 9604 does not elevate IGF-1 levels, does not affect blood sugar regulation, and does not carry the risks associated with exogenous growth hormone use
Start with education and clinic-directed guidance through Revolution Health.
Key dates Information webinar: 6 July 2026, 15:00 to 17:00 CEST Stage 0, Expression of Interest (mandatory): 1 July to 10 September 2026 Stage 1, Short Proposal: 15 September to 29 October 2026 Full details of the ECTC 2026 are available on the ERDERA call page, including the pre-announcement of the call, the official call text and application documents published at the launch on 1 July
